GE HealthCare Stock (US36266G1076): Analyst caution and recent earnings keep the shares in view

GE HealthCare is back in focus after fresh analyst action and a mixed quarterly backdrop, while market data shows the stock trading around $65.18 on Friday.

Responsible: ad hoc news Stocks & Analysis Desk. Reviewed prior to publication on June 13, 2026 at 7:46 PM ET. Details in the imprint.

GE HealthCare stock is in focus after a new analyst note and a mixed earnings backdrop pushed the US-listed shares back into the discussion. MarketBeat said GEHC opened at $65.18 on Friday, while ad-hoc-news pointed to the company after new price targets and the latest quarterly picture.

Analyst sentiment stays guarded

Bank of America Securities reiterated a Hold rating on GE HealthCare Technologies and set a $74.00 price target, according to a report released today. MarketBeat also said the broader analyst tally currently stands at nine Buy ratings and nine Hold ratings, which leaves the stock with a consensus Moderate Buy and an average target of $80.21.

That split matters because GE HealthCare trades on the Nasdaq under ticker GEHC, and the analyst debate is now centered on how much of the companys earnings recovery is already reflected in the share price. The stock is also tracked as part of the Nasdaq universe, which keeps it on the radar of US retail investors looking at large-cap healthcare names.

Recent earnings data add to that cautious tone. A Globe and Mail market item said the companys quarter ended March 31 included $513 billion in revenue and $389 million in net income, while ad-hoc-news described the quarterly balance as mixed.

Those figures suggest investors are still weighing scale, margins, and valuation together rather than reacting to a single headline. For a healthcare equipment maker with global hospital and imaging exposure, that combination often leads to slower, more selective trading than a pure growth story.

GE HealthCare's listing details also matter for readers following the US market. The company trades in US dollars on the Nasdaq, and the current coverage frame ties the stock to a valuation debate rather than a fresh corporate event such as a deal or guidance reset.

For now, the shares are being judged on whether earnings can justify the current analyst targets and the market price around $65.18. If the next catalyst comes from guidance, margin progress, or another analyst revision, the stock could stay active even without a broader sector move.

GE HealthCare at a glance

• Name: GE HealthCare Technologies Inc.
• Industry: Healthcare equipment and medical imaging
• Headquarters: Chicago, Illinois, USA
• Core markets: Diagnostic imaging, patient monitoring, ultrasound, and pharmaceutical diagnostics
• Revenue drivers: Hospital imaging systems, service contracts, consumables, and software-enabled clinical tools
• Listing: Nasdaq, ticker GEHC
• Trading currency: US dollars

This article was created with a.i. assistance and editorially reviewed. Not investment advice, not a buy or sell recommendation. Trading in securities carries risks up to the total loss of capital.